It isa new lipase inhibitor Xinli Division him (ATL-962) of obese patients randomized placebo-controlled 12-week study "confirmed that the 12-weeks, each 60mg, 3 times a day, weight reduce 3.3kg; each 120mg, 3 times a day, weight loss 3.5kg; each 240mg, 3 times a day, weight loss 4.1kg. hyperlipidemia in patients with blood cholesterol levels and LDL cholesterol levels are reduced in each group 3 ~ 11% using the new Secretary for his benefits, 12 weeks effective.